These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4582564)

  • 21. Clinical trial of BCNU (NSC-409962) combined with vincristine (NSC-67574) in disseminated gastrointestinal cancer and other neoplasms.
    Stolinsky DC; Pugh RP; Bohannon RA; Bogdon DL; Bateman JR
    Cancer Chemother Rep; 1974; 58(6):947-50. PubMed ID: 4614902
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase II evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in patients with solid tumors.
    Ramirez G; Wilson W; Grage T; Hill G
    Cancer Chemother Rep; 1972 Dec; 56(6):787-90. PubMed ID: 4574056
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
    Moertel CG
    Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.
    Lokich JJ; Skarin AT
    Cancer Chemother Rep; 1972 Oct; 56(5):653-7. PubMed ID: 4569058
    [No Abstract]   [Full Text] [Related]  

  • 25. Stimulation of ultraviolet-induced carcinogenesis by 1,3-Bis(2-chloroethyl)-1-nitrosourea.
    Epstein JH
    Cancer Res; 1979 Feb; 39(2 Pt 1):408-10. PubMed ID: 761213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical studies with nitrosoureas in various solid tumors.
    Slavik M
    Cancer Treat Rep; 1976 Jun; 60(6):795-800. PubMed ID: 986243
    [No Abstract]   [Full Text] [Related]  

  • 27. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
    Carter SK; Newman JW
    Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.
    Olshin S; Siddiqui S; Firat D
    Cancer Chemother Rep; 1972 Apr; 56(2):259-61. PubMed ID: 5043228
    [No Abstract]   [Full Text] [Related]  

  • 29. An evaluation of adrenalectomy and androgen in disseminated mammary carcinoma.
    Dao TL; Nemoto T
    Surg Gynecol Obstet; 1965 Dec; 121(6):1257-62. PubMed ID: 4158865
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase I evaluation of the combination 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and dianhydrogalactitol (DAG; NSC-132313) in patients with advanced neoplastic diseases.
    Creagan ET; Eagan RT; Rubin J
    Med Pediatr Oncol; 1979; 7(2):179-80. PubMed ID: 502975
    [No Abstract]   [Full Text] [Related]  

  • 31. Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.
    Panella TJ; Smith DC; Schold SC; Rogers MP; Winer EP; Fine RL; Crawford J; Herndon JE; Trump DL
    Cancer Res; 1992 May; 52(9):2456-9. PubMed ID: 1533174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
    Bellett RE; Mastrangelo MJ; Laucius JF; Bodurtha AJ
    Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: Calusterone (NSC-88536) in advanced breast cancer.
    Falkson G; Falkson HC
    Cancer Treat Rep; 1976 Mar; 60(3):220-1. PubMed ID: 130973
    [No Abstract]   [Full Text] [Related]  

  • 34. Pilot study evaluating 1,3-bis(2-chloroethyl)-1-nitrosourea in the treatment of advanced ovarian carcinoma.
    Jorgensen EO; Malkasian GD; Webb MJ; Hahn RG
    Am J Obstet Gynecol; 1973 Jul; 116(6):769-70. PubMed ID: 4577261
    [No Abstract]   [Full Text] [Related]  

  • 35. Amphotericin B induction of sensitivity to adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) plus cyclophosphamide in human neoplasia.
    Presant CA; Klahr C; Santala R
    Ann Intern Med; 1977 Jan; 86(1):47-51. PubMed ID: 264783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
    van Eden EB; Falkson HC; Falkson G
    Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624
    [No Abstract]   [Full Text] [Related]  

  • 37. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II clinical trials of BCNU )NSC-409962) and bleomycin (NSC-125066) in the treatment of Kaposi's sarcoma.
    Vogel CL; Clements D; Wanume AK; Toya T; Primack A; Kyalwazi S
    Cancer Chemother Rep; 1973; 57(3):325-33. PubMed ID: 4127394
    [No Abstract]   [Full Text] [Related]  

  • 39. 5-Fluorouracil (NSC-19893), DTIC (NSC-45388), BCNU (NSC-409962), and vincristine (NSC-67574) in advanced colorectal carcinoma.
    von Eyben FE; Larsen V; Pedersen H
    Cancer Treat Rep; 1976 Jan; 60(1):29-32. PubMed ID: 1000517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Walter Hubert lecture Chemotherapy of upper gastrointestinal carcinoma.
    Moertel CG
    Br J Cancer; 1976 Sep; 34(3):325-34. PubMed ID: 184809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.